Centre Léon Berard

Lyon 69373

0 studies enrolling now · 7 studies all time

What they study most

Castration-resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors, HER2 Amplification, HER2 Gene Mutation, HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, Osteosarcoma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Prostate Cancer Metastatic

Studies at this site

• Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs — Running, not enrolling
• ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer — Running, not enrolling
• Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer — Completed
• HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Stopped early
• A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma — Completed
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer — Completed